Treatment of Overweight in General Practice
1 other identifier
interventional
23
0 countries
N/A
Brief Summary
In this study the investigators want to explore the feasibility and effect of a simple intervention provided by primary care physicians on treatment for overweight in general practice. Regular patients visiting their ordinary family physician will be asked for participation if they comply with the inclusion criteria. If so, they will follow a detailed food list for 12 months with regular visits to the doctor. At each visit, the participating patients will be asked about their progress on weight loss and all measurements will be made. Simultaneously a control group of primary care physicians will also recruit patients that fulfill the inclusion criteria. These patients will also provide data that will serve as Control to the intervention group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2017
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2016
CompletedFirst Posted
Study publicly available on registry
December 21, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedJune 22, 2021
June 1, 2021
1.9 years
December 13, 2016
June 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight reduction
10% weight reduction measured as kilo weight at inclusion
12 months
Secondary Outcomes (4)
Blood pressure
12 months
HbA1c
12 months
Waist measure
12 months
Total Cholesterol
12 months
Other Outcomes (1)
Qualitative study
24 months
Study Arms (2)
Intervention group
EXPERIMENTAL12 Family physicians in primary care will constitute the Intervention group. They will enroll 10 patients each from their ordinary practice. The physicians will be provided with a specific course on the treatment model of the study, including how to collect and register data. They will have a detailed manual indicating the content of each visit. Following recruitment and consent, the patient will meet for the first visit in the study one week later. At this visit the patient will be provided with detailed information on the content and preparation for all meals. Data will be collected. The manual describes a diet in accordance with official guidelines providing the patient 1600Kcal per day. The following visits will take place after 4 weeks, 8 weeks, 4 months, 8 months and 12 months from the first visit. Data will be collected at all visits, and also at 6 and 12 months follow-up.
Control group
NO INTERVENTION12 Family physicians in primary care will constitute the Control group. They will enroll 10 patients each from their ordinary practice. The physicians will not be provided with any information of the treatment model of the study but they will have all information about how to collect and register data. The patients on this group will also sign consent to provide data and therefore they will know about the study but they do not get any specific information about weight loss other than the general information that their physician may tell them. The patients in the Control Group will be asked to give data on inclusion visit and again 12 months later, and also at 6 and 12 months thereafter (i.e. 0, 12, 18 and 24 months from inclusion).
Interventions
Eligibility Criteria
You may qualify if:
- BMI \_\> 30 OR \_25 With at least one Medical condition related to overweight (hypertension, dyslipidemia, metabolic syndrome, diabetes mellitus II, hip- or knee pain)
- written consent
- sufficient knowledge in Norwegian Language to acquire the written and oral information
You may not qualify if:
- any ongoing cancer condition
- any current medication impacting on weight
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Nilsen MD, Mdala I, Werner EL. Treatment of overweight and obesity in general practice: a cluster randomised trial. BMJ Nutr Prev Health. 2023 Nov 29;6(2):326-331. doi: 10.1136/bmjnph-2023-000721. eCollection 2023.
PMID: 38618545DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jørund Straand, Prof., Ph.D
University of Oslo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- ID of participating patients are only available through the participating Family phyisican
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 13, 2016
First Posted
December 21, 2016
Study Start
January 1, 2017
Primary Completion
December 1, 2018
Study Completion
December 1, 2019
Last Updated
June 22, 2021
Record last verified: 2021-06